Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome.
about
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infectionAdjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infectionAdjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection: a meta-analysis of randomised controlled trials.Corticosteroids in acute respiratory failureImmunological features of Pneumocystis carinii infection in humans.Pulmonary aspergillosis as opportunistic mycoses in a cohort of human immunodeficiency virus-infected patients: Report from a tertiary care hospital in North India.Clinical significance of positive Pneumocystis jirovecii polymerase chain reaction in non-human immunodeficiency virus immunocompromised patients in a real practice.Aerosolized antimicrobial therapy in acutely ill patients.Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumoniaImmunorestitution disease involving the innate and adaptive response.Local delivery of the viral interleukin-10 gene suppresses tissue inflammation in murine Pneumocystis carinii infection.HIV-related Pneumocystis carinii pneumonia in older patients hospitalized in the early HAART era.Pneumocystis carinii pneumonia: a review of current issues in diagnosis and management.The impact of concomitant pulmonary infection on immune dysregulation in Pneumocystis jirovecii pneumoniaAIDS related opportunistic infections, going but not gone.Outcomes of moderate-to-severe Pneumocystis pneumonia treated with adjunctive steroid in non-HIV-infected patientsAdjuvant corticosteroid therapy for Pneumocystis carinii pneumonia in AIDS patients.Sensitized splenocytes result in deleterious cytokine cascade and hyperinflammatory response in rats with Pneumocystis pneumonia despite the presence of corticosteroidsManagement of Pneumocystis Jirovecii pneumonia in HIV infected patients: current options, challenges and future directions.Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal.The major surface glycoprotein of Pneumocystis carinii induces release and gene expression of interleukin-8 and tumor necrosis factor alpha in monocytesA 21-Day of Adjunctive Corticosteroid Use May Not Be Necessary for HIV-1-Infected Pneumocystis Pneumonia with Moderate and Severe Disease.Current status of HIV therapy: II. Opportunistic diseases.Pneumocystis carinii: A review of an important opportunistic pathogen in AIDSOpportunistic infections in HIV-infected patients.Pharmacotherapy for human immunodeficiency virus-associated nephropathy.Clinical review: a systematic review of corticosteroid use in infections.Adjunctive corticosteroids for the treatment of Pneumocystis jiroveci pneumonia in patients with HIV: A meta-analysisPneumocystis pneumonia in a non-HIV patient on chronic corticosteroid therapy: a question of prophylaxisClinical review: Respiratory failure in HIV-infected patients--a changing picture.Critical roles of inflammation and apoptosis in improved survival in a model of hyperoxia-induced acute lung injury in Pneumocystis murina-infected mice.Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study.Novel composite efficacy measure to demonstrate the rationale and efficacy of combination antiviral-anti-inflammatory treatment for recurrent herpes simplex labialis.Update on the diagnosis and treatment of Pneumocystis pneumonia.Prognosis of pneumocystis pneumonia complicated in patients with rheumatoid arthritis (RA) and non-RA rheumatic diseases.Comparison of community-acquired pneumonia requiring admission to hospital in HIV-and non-HIV-infected patients.The Impact of Established Immunoregulatory Networks on Vaccine Efficacy and the Development of Immunity to Malaria.Pneumocystis pneumonia complicating immunosuppressive therapy in Crohns disease: A preventable problem?Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.Adjunctive therapy for severe hypoxic pneumonia in HIV-infected and HIV-exposed children in low- and middle-income countries.
P2860
Q24186646-3C90641C-4BCA-4870-AB98-402A33C4E860Q24245547-638AC7DD-361F-4E31-92CA-8CD980022942Q24815855-C98D0388-B64D-4BBD-817C-0B491CAD22A1Q28145486-62790A09-3A6D-4860-BFC6-5BBF2BD7566AQ33538931-C3D16B08-CA65-454D-B8FC-DFBE37370033Q33662384-47AD5B37-46AA-4B1F-9002-00114375847AQ33690687-3E6AEFB6-2B57-4539-9F85-F26FB96E50E4Q33839762-E6791DBA-2A94-4C11-A116-110D01A57044Q33901918-C7535445-1E16-4527-A482-8A77A23E5265Q33958197-D652C80A-535E-43E8-AD57-3EDC0D964191Q34185923-FE20AD53-B6B2-46BC-8734-62B5A717BED6Q34369663-1FA4A52E-4AD1-4C7A-B131-A68553B8E901Q34459389-1A4B01CA-BC05-497D-B795-A7B23596D2E8Q34587043-5A24EBC5-7E6A-4FF8-8E2D-881EB039991DQ34756259-2C851E3F-D509-470F-B2D9-AC96A8A62FFFQ35270593-D74629C1-F9DA-47FC-A541-583D30717C3BQ35466711-9ACAAF38-7D7E-41F3-9EAE-4C8F75222111Q35550705-3093EA8D-7B47-4538-AA99-1ACFDC4D3D93Q35557252-0C87C184-3020-431E-B6D9-4AF650CA2E3DQ35557331-6AAEC747-E12D-44A3-BDE0-55C9A42591F4Q35558888-8CD7E2C2-FE3C-4655-B730-676E5CF6CC38Q35783289-19A6A7B2-51D8-4D34-A319-23E8EA831953Q35819631-40770775-F95C-4A1E-B471-60127676DB59Q35839154-253F4CAD-6909-4D76-9A8F-C1A4EE4E4400Q35893214-F12C5726-677F-411A-BA90-968FFB897AA5Q36320626-71315B37-3C25-400D-B776-08113B243A9FQ36342706-BCCC7175-D21C-4453-974B-4FC05E93127AQ36524565-19A9129D-F477-48C0-8BE9-00BA41A99697Q36745959-B7DD1C4B-C84B-4382-A6F8-3518FFEB6667Q36998358-02CA1CA2-805D-4102-B633-A4CB96ED891CQ37099469-EB02E986-49F6-496C-BDA9-5517DC17DF7FQ37417520-88E9FA00-48C2-4C10-BB59-D435B6F5DAC2Q37643645-CDB6A367-83EA-4F61-9AA5-742D847D586AQ37782191-1178B3AF-5D89-43A8-9FFF-F23BD10698F4Q37942495-2B20EF55-090D-440B-B3F7-0D283AC6E60EQ38003601-56791045-28BB-45D8-BC0F-5D310D6CBE40Q39027956-16A85D44-259A-43AC-BB41-B29F532B8776Q40080089-59A8C3BF-8E1D-47F4-A933-4D11AF57853AQ40092648-D5D5A6A2-65E8-423C-BF77-EF7500325F22Q40344932-B69CCB91-D2A8-4F54-AD33-963A054D907D
P2860
Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome.
description
1990 nî lūn-bûn
@nan
1990 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Consensus statement on the use ...... red immunodeficiency syndrome.
@ast
Consensus statement on the use ...... red immunodeficiency syndrome.
@en
Consensus statement on the use ...... red immunodeficiency syndrome.
@nl
type
label
Consensus statement on the use ...... red immunodeficiency syndrome.
@ast
Consensus statement on the use ...... red immunodeficiency syndrome.
@en
Consensus statement on the use ...... red immunodeficiency syndrome.
@nl
prefLabel
Consensus statement on the use ...... red immunodeficiency syndrome.
@ast
Consensus statement on the use ...... red immunodeficiency syndrome.
@en
Consensus statement on the use ...... red immunodeficiency syndrome.
@nl
P1476
Consensus statement on the use ...... red immunodeficiency syndrome.
@en
P2093
National Institutes of Health- ...... apy for Pneumocystis Pneumonia
P304
P356
10.1056/NEJM199011223232131
P407
P577
1990-11-01T00:00:00Z